AUD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -3.02 Million AUD | -3.56% |
2023 | -2.91 Million AUD | 13.42% |
2022 | -3.77 Million AUD | 4.31% |
2021 | -4.24 Million AUD | -88.99% |
2020 | -2.47 Million AUD | -261.28% |
2019 | -1190.00 AUD | -233.9% |
2018 | 191.00 AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -1.5 Million AUD | 18.11% |
2024 FY | - AUD | 23.81% |
2024 Q4 | -1.53 Million AUD | -1.65% |
2023 Q4 | -1.84 Million AUD | 14.33% |
2023 Q2 | -2.15 Million AUD | 2.92% |
2023 FY | - AUD | 13.42% |
2022 Q4 | -2.21 Million AUD | 6.48% |
2022 Q2 | -2.37 Million AUD | 23.32% |
2022 FY | - AUD | 4.31% |
2021 Q4 | -3.09 Million AUD | -81.54% |
2021 FY | - AUD | -88.99% |
2021 Q2 | -1.7 Million AUD | -54.21% |
2020 Q4 | -1.1 Million AUD | 22.92% |
2020 FY | - AUD | -261.28% |
2020 Q2 | -1.43 Million AUD | -148.7% |
2019 FY | - AUD | -233.9% |
2019 Q4 | -576.24 Thousand AUD | 0.0% |
2018 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alcidion Group Limited | -4.49 Million AUD | 32.818% |
Artrya Limited | -13.95 Million AUD | 78.355% |
Beamtree Holdings Limited | -331 Thousand AUD | -812.544% |
Cogstate Limited | 9.89 Million AUD | 130.537% |
Careteq Limited | -826.61 Thousand AUD | -265.408% |
Doctor Care Anywhere Group PLC | -8.35 Million AUD | 63.843% |
Emyria Limited | -13.03 Million AUD | 76.827% |
Global Health Limited | -1.76 Million AUD | -71.059% |
HITIQ Limited | -2.54 Million AUD | -18.796% |
ImExHS Limited | -1.25 Million AUD | -140.158% |
Mach7 Technologies Limited | -2.44 Million AUD | -23.688% |
MedAdvisor Limited | 7.04 Million AUD | 142.855% |
Oakridge International Limited | -630.05 Thousand AUD | -379.407% |
Opyl Limited | -3.2 Million AUD | 5.881% |
PainChek Limited | -9.48 Million AUD | 68.167% |
Pro Medicus Limited | 120.76 Million AUD | 102.501% |
Resonance Health Limited | -457 Thousand AUD | -560.934% |
Singular Health Group Ltd | -2.88 Million AUD | -4.693% |
Total Brain Limited | -5.49 Million AUD | 44.993% |